Literature DB >> 14969058

The Norfolk Arthritis Register (NOAR).

D P Symmons1, A J Silman.   

Abstract

The Norfolk Arthritis Register (NOAR) has been recruiting and following patients with early inflammatory polyarthritis (IP) since 1989. Approximately three-quarters of the patients followed satisfy classification criteria for rheumatoid arthritis (RA) by 5 years from symptom onset. This paper summarises the publications which have been based on the NOAR cohort with respect to the incidence and prevalence of IP and RA, genetic and environmental risk factors for the development of IP, outcome following the development of IP and predictors of outcome. It also discusses methodological issues in examining the treatment effect in observational cohorts and the costs to the healthcare system of patients with early IP.

Entities:  

Mesh:

Year:  2003        PMID: 14969058

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  34 in total

Review 1.  Epidemiology research in rheumatology-progress and pitfalls.

Authors:  Deborah P M Symmons
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

Review 2.  Swedish registers to examine drug safety and clinical issues in RA.

Authors:  J Askling; C M Fored; P Geborek; L T H Jacobsson; R van Vollenhoven; N Feltelius; S Lindblad; L Klareskog
Journal:  Ann Rheum Dis       Date:  2006-01-13       Impact factor: 19.103

3.  Disease activity and functional changes of RA patients receiving different DMARDs in clinical practice.

Authors:  Manathip Osiri; Utis Deesomchok; Peter Tugwell
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

Review 4.  Environmental and gene-environment interactions and risk of rheumatoid arthritis.

Authors:  Elizabeth W Karlson; Kevin Deane
Journal:  Rheum Dis Clin North Am       Date:  2012-05-30       Impact factor: 2.670

5.  Designing a decision support system for existing clinical organizational structures: considerations from a rheumatology clinic.

Authors:  Orjan Dahlström; Ingrid Thyberg; Ursula Hass; Thomas Skogh; Toomas Timpka
Journal:  J Med Syst       Date:  2006-10       Impact factor: 4.460

6.  Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment.

Authors:  Teresa A Simon; Johan Askling; Diane Lacaille; Jarrod Franklin; Frederick Wolfe; Allison Covucci; Samy Suissa; Marc C Hochberg
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

7.  Influence of arthritis and non-arthritis related factors on areal bone mineral density (BMDa) in women with longstanding inflammatory polyarthritis: a primary care based inception cohort.

Authors:  Stephen R Pye; Tarnya Marshall; Karl Gaffney; Alan J Silman; Deborah P M Symmons; Terence W O'Neill
Journal:  BMC Musculoskelet Disord       Date:  2010-05-28       Impact factor: 2.362

8.  Disease activity and severity in early inflammatory arthritis predict hand cortical bone loss.

Authors:  Stephen R Pye; Judith E Adams; Kate A Ward; Diane K Bunn; Deborah P M Symmons; Terence W O'Neill
Journal:  Rheumatology (Oxford)       Date:  2010-06-23       Impact factor: 7.580

Review 9.  Approaches to the treatment of early rheumatoid arthritis with disease-modifying antirheumatic drugs.

Authors:  Lyudmila Sizova
Journal:  Br J Clin Pharmacol       Date:  2008-05-15       Impact factor: 4.335

10.  Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment.

Authors:  T A Simon; A L Smitten; J Franklin; J Askling; D Lacaille; F Wolfe; M C Hochberg; K Qi; S Suissa
Journal:  Ann Rheum Dis       Date:  2008-12-03       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.